1. Home
  2. AVXL vs EZPW Comparison

AVXL vs EZPW Comparison

Compare AVXL & EZPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • EZPW
  • Stock Information
  • Founded
  • AVXL 2004
  • EZPW 1989
  • Country
  • AVXL United States
  • EZPW United States
  • Employees
  • AVXL N/A
  • EZPW N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • EZPW Other Specialty Stores
  • Sector
  • AVXL Health Care
  • EZPW Consumer Discretionary
  • Exchange
  • AVXL Nasdaq
  • EZPW Nasdaq
  • Market Cap
  • AVXL 956.7M
  • EZPW 1.0B
  • IPO Year
  • AVXL N/A
  • EZPW 1991
  • Fundamental
  • Price
  • AVXL $8.78
  • EZPW $17.07
  • Analyst Decision
  • AVXL Strong Buy
  • EZPW Strong Buy
  • Analyst Count
  • AVXL 2
  • EZPW 3
  • Target Price
  • AVXL $44.00
  • EZPW $19.33
  • AVG Volume (30 Days)
  • AVXL 944.5K
  • EZPW 576.8K
  • Earning Date
  • AVXL 08-12-2025
  • EZPW 11-12-2025
  • Dividend Yield
  • AVXL N/A
  • EZPW N/A
  • EPS Growth
  • AVXL N/A
  • EZPW 23.23
  • EPS
  • AVXL N/A
  • EZPW 1.29
  • Revenue
  • AVXL N/A
  • EZPW $1,232,018,000.00
  • Revenue This Year
  • AVXL N/A
  • EZPW $9.93
  • Revenue Next Year
  • AVXL N/A
  • EZPW $6.42
  • P/E Ratio
  • AVXL N/A
  • EZPW $13.39
  • Revenue Growth
  • AVXL N/A
  • EZPW 8.31
  • 52 Week Low
  • AVXL $5.03
  • EZPW $10.56
  • 52 Week High
  • AVXL $14.44
  • EZPW $17.53
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 39.78
  • EZPW 65.46
  • Support Level
  • AVXL $8.85
  • EZPW $16.51
  • Resistance Level
  • AVXL $9.69
  • EZPW $17.53
  • Average True Range (ATR)
  • AVXL 0.55
  • EZPW 0.38
  • MACD
  • AVXL -0.02
  • EZPW -0.04
  • Stochastic Oscillator
  • AVXL 1.82
  • EZPW 62.30

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About EZPW EZCORP Inc. Non Voting

EZCORP Inc is a United States-based company engaged in offering pawn loans in the United States and Mexico. It also offers short-term unsecured loans and other consumer financial products, and buy and sell second-hand goods. The operating segments of the company are us Pawn, Latin America Pawn, and other international. us Pawn segment includes all pawn activities in the United States. Latin America Pawn segment includes all pawn activities in Mexico and other parts of Latin America. The company generates revenue from merchandise sales, jewelry scrapping sales, and pawn service charges, of which key revenue is derived from the merchandise sales which are primarily collateral forfeited from pawn lending operations and used merchandise purchased from the customers.

Share on Social Networks: